Search research articles
Contact Us
Filters
Showing results (301-310 of 532) with videos related to
Page
of 54
Sort By:
Synapse (New York, N.Y.)
|
September 16, 2010
Evidence for noncompetitive modulation of substrate-induced serotonin release
Richard B Rothman, Michael H Baumann, Bruce E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 13, 2006
Interaction of amphetamines and related compounds at the vesicular monoamine transporter
John S Partilla, Allison G Dempsey, Ameet S Nagpal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 22, 2004
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')
Michael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Biological Psychiatry
|
December 1, 1995
Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers
M H Baumann, T M Gendron, K M Becketts, et al.
Bioorganic & Medicinal Chemistry
|
August 21, 2003
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans
Subramaniam Ananthan, Naveen K Khare, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2003
Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter
David Lewis, Ying Zhang, Thomas Prisinzano, et al.
European Journal of Medicinal Chemistry
|
July 25, 2013
Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylation
Hwan Jung Lim, Christina M Dersch, Richard B Rothman, et al.
Journal of Medicinal Chemistry
|
April 9, 2008
Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters
Ling-Wei Hsin, Li-Te Chang, Richard B Rothman, et al.
Annals of the New York Academy of Sciences
|
July 10, 2002
Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence
Michael H Baumann, Jennifer M Phillips, Mario A Ayestas, et al.
Annals of the New York Academy of Sciences
|
November 21, 2000
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction
R B Rothman, J S Partilla, C M Dersch, et al.
Page
of 54
Search research articles
Search
Showing results (301-310 of 532) with videos related to
Sort By:
Page
of 54
Synapse (New York, N.Y.)
|
September 16, 2010
Evidence for noncompetitive modulation of substrate-induced serotonin release
Richard B Rothman, Michael H Baumann, Bruce E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 13, 2006
Interaction of amphetamines and related compounds at the vesicular monoamine transporter
John S Partilla, Allison G Dempsey, Ameet S Nagpal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 22, 2004
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')
Michael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Biological Psychiatry
|
December 1, 1995
Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers
M H Baumann, T M Gendron, K M Becketts, et al.
Bioorganic & Medicinal Chemistry
|
August 21, 2003
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans
Subramaniam Ananthan, Naveen K Khare, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2003
Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporter
David Lewis, Ying Zhang, Thomas Prisinzano, et al.
European Journal of Medicinal Chemistry
|
July 25, 2013
Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylation
Hwan Jung Lim, Christina M Dersch, Richard B Rothman, et al.
Journal of Medicinal Chemistry
|
April 9, 2008
Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters
Ling-Wei Hsin, Li-Te Chang, Richard B Rothman, et al.
Annals of the New York Academy of Sciences
|
July 10, 2002
Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence
Michael H Baumann, Jennifer M Phillips, Mario A Ayestas, et al.
Annals of the New York Academy of Sciences
|
November 21, 2000
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction
R B Rothman, J S Partilla, C M Dersch, et al.
Page
of 54